News
![Rosamond_Deegan](https://pharmaphorum.com/wp-content/uploads/2020/02/Rosamond_Deegan.png)
Google, Sanofi back UK biotech OMass' $100m second round
OMass Therapeutics has raised an impressive $100 million in a Series B financing that is said to be the largest ever for a UK biotech focusing on small-molecule drug development.